Does Dietary Restriction Alter Stem Cell Function Through An Epigenetic Mechanism?
Does Dietary Restriction Alter Stem Cell Function Through An Epigenetic Mechanism?
批准号:
9920075
负责人:
WILLARD M FREEMAN
金额:
$22.38万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-01 至 2022-01-31
关键词:
AffectAgeAgingAnimalsBiological AssayBiological MarkersCell physiologyCellsChromatinChronologyCpG IslandsCytosineDNADNA MethylationDNA Modification MethylasesDNA-Binding ProteinsDataData SetDiseaseEnhancersEpigenetic ProcessEpithelial CellsEquilibriumGene ExpressionGenesGenetic TranscriptionGenomeGenomicsGoalsGrantHuman GenomeInterventionIntestinal MucosaIntestinesKnowledgeLaboratoriesLeadLifeLongevityMaintenanceMeasuresMediatingMemoryMethylationMolecularMusNucleic Acid Regulatory SequencesOrganismPathway interactionsPlayRegulator GenesResearchResolutionRodentRoleSeminalSignal TransductionSiteTestingTissuesage effectage relatedanti agingbasedietary restrictionhealthspanimprovedinsightinterestmouse genomenext generation sequencingnovelpreventpromoterstem cellstranscription factortranscriptometranscriptome sequencingtranscriptomics
中文摘要
在所有被证明可以延长寿命的干预措施中,饮食限制(DR)是研究最多的
英文摘要
Of all the interventions that have been shown to increase lifespan, dietary restriction (DR) is the most studied
and universal aging intervention. Because DR also delays the onset and progression of most age-related
diseases as well as maintaining healthspan, it is well accepted that DR increases lifespan by delaying/retarding
aging. However, we still do not understand the mechanism(s) responsible for the anti-aging effect of DR. An important
aspect of DR that has been largely overlooked is that when implemented early in life DR can increase lifespan
of rodents even when rodents are fed ad libitum (AL) the remainder of their life. This provides compelling
evidence that DR acts through a mechanism that involves a molecular signal(s) that arises shortly after the
implementation of DR and has an impact on the animal over its lifespan, even after DR is discontinued, e.g., an
epigenetic mechanism, such as DNA methylation. Functionally, DNA methylation (5mC) can regulate chromatin
status and affect the ability of transcription factors and other DNA binding proteins to access DNA and regulate
gene expression, thereby altering the function of cells and tissues. Several groups, including our laboratories,
have shown that DR alters DNA methylation in tissues of mice, reversing many of the changes in DNA
methylation that occur with age as well as inducing changes in DNA methylation that do not change with age.
Recently we found that short-term DR induces changes in DNA methylation in intestinal mucosa in the promoter
of the Nts 1 gene. The changes in DNA methylation are closely associated with increased expression of Nts 1,
which persist when the DR mice are then fed ad libitum for several months. Because the epithelial cells in the
intestinal mucosa are continuously renewed every 4 to 5 days, the changes in DNA methylation we observed in
intestinal mucosa most likely arise in intestinal stem cells. Therefore, we hypothesize that DR induces changes
in DNA methylation in intestinal stem cells at specific genomic sites that results in a molecular memory, which
potentially leads to alterations in the expression of genes that are important in intestinal stem cell function. In
this project, we will measure changes in DNA methylation (5mC) and hydroxymethylation (5hmC) induced by
DR in intestinal stem cells using a novel assay developed by our group, which allows us to measure accurately
at single base resolution changes in both 5mC and 5hmC at ~ 30 million specific sites in the genome. In this R21
grant, we will test our hypothesis in the following specific aims.
Aim 1: Determine the effect of DR on DNA methylation and hydroxymethylation across gene regulatory regions
of the genome of stem cells isolated from the intestines of three groups of mice: mice fed AL, mice fed DR for 4
months, and DR mice fed DR for 4 months and then fed AL for 6 months.
Aim 2: Identify changes in transcription that could arise from changes in DNA methylation/hydroxymethylation
and play a role in intestinal stem cell function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BLRD Research Career Scientist Award Application
-
批准号:10594024
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:WILLARD M FREEMAN
-
依托单位:
Sex divergence and cell specificity of age-related hippocampal DNA modifications
-
批准号:9766020
-
项目类别:
-
资助金额:$49.11万
-
财政年份:2019
-
负责人:WILLARD M FREEMAN
-
依托单位:
MOLECULAR ANALYSIS CELLULAR IMAGING (MACI) CORE
-
批准号:10536646
-
项目类别:
-
资助金额:$41.2万
-
财政年份:2019
-
负责人:WILLARD M FREEMAN
-
依托单位:
MOLECULAR ANALYSIS CELLULAR IMAGING (MACI) CORE
-
批准号:10320857
-
项目类别:
-
资助金额:$37.95万
-
财政年份:2019
-
负责人:WILLARD M FREEMAN
-
依托单位:
ShEEP Request for Laser Microdissection Instrument
-
批准号:9796446
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:WILLARD M FREEMAN
-
依托单位:
Sex divergence and cell specificity of age-related hippocampal DNA modifications
-
批准号:10063357
-
项目类别:
-
资助金额:$56.35万
-
财政年份:2019
-
负责人:WILLARD M FREEMAN
-
依托单位:
Sex divergence and cell specificity of age-related hippocampal DNA modifications
-
批准号:10385743
-
项目类别:
-
资助金额:$53.57万
-
财政年份:2019
-
负责人:WILLARD M FREEMAN
-
依托单位:
Sex divergence and cell specificity of age-related hippocampal DNA modifications
-
批准号:10615662
-
项目类别:
-
资助金额:$53.55万
-
财政年份:2019
-
负责人:WILLARD M FREEMAN
-
依托单位:
MOLECULAR ANALYSIS CELLULAR IMAGING (MACI) CORE
-
批准号:10077912
-
项目类别:
-
资助金额:$36.3万
-
财政年份:2019
-
负责人:WILLARD M FREEMAN
-
依托单位:
Dynamics of the brain epigenome with aging
-
批准号:9898315
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:WILLARD M FREEMAN
-
依托单位:
Dynamics of the brain epigenome with aging
-
批准号:10158418
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:WILLARD M FREEMAN
-
依托单位:
Genomic Sciences Core
-
批准号:10261477
-
项目类别:
-
资助金额:$18.51万
-
财政年份:2015
-
负责人:WILLARD M FREEMAN
-
依托单位:
Defective mitochondrial function & genomic maintenance with diabetic retinopathy
-
批准号:9143129
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2015
-
负责人:WILLARD M FREEMAN
-
依托单位:
Genomic Sciences Core
-
批准号:10424598
-
项目类别:
-
资助金额:$18.68万
-
财政年份:2015
-
负责人:WILLARD M FREEMAN
-
依托单位:
Genomic Sciences Core
-
批准号:10044526
-
项目类别:
-
资助金额:$17.68万
-
财政年份:2015
-
负责人:WILLARD M FREEMAN
-
依托单位:
Genomic Sciences Core
-
批准号:10649626
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2015
-
负责人:WILLARD M FREEMAN
-
依托单位:
INSULIN-THERAPY RESISTANT EPIGENETIC MODIFICATIONS IN DIABETIC RETINOPATHY
-
批准号:8843158
-
项目类别:
-
资助金额:$31.77万
-
财政年份:2014
-
负责人:WILLARD M FREEMAN
-
依托单位:
INSULIN-THERAPY RESISTANT EPIGENETIC MODIFICATIONS IN DIABETIC RETINOPATHY
-
批准号:8704314
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2014
-
负责人:WILLARD M FREEMAN
-
依托单位:
Insulin-therapy resistant epigenetic modifications in diabetic retinopathy
-
批准号:8131484
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2011
-
负责人:WILLARD M FREEMAN
-
依托单位:
Insulin-therapy resistant epigenetic modifications in diabetic retinopathy
-
批准号:8512731
-
项目类别:
-
资助金额:$0.93万
-
财政年份:2011
-
负责人:WILLARD M FREEMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: